Five months ago, J&J also revealed its plan to spend $2 billion over the next 10 years to operate a 160,000-square-foot ...

The New Jersey pharma will now offer some of its branded medicines on the US government-created DTC platform, TrumpRx.gov.

GlobalData’s detailed strategic reports on the MFN executive order and on the GENEROUS model examined how some of the known ...

Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing agreement with the Trump ...

Most Americans likely will not benefit immediately from efforts to lower prescription prices. Administration officials expect ...

And another firm has reached a most-favored nation (MFN) pricing deal with the White House. Johnson & Johnson announced Jan. 8 a voluntary agreement with the Trump administration aimed at improving ...

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...

Johnson & Johnson JNJ recently signed a landmark agreement with the Trump administration to lower drug prices in the United ...

Johnson & Johnson's agreement with the Trump administration enables patients to access drugs at a comparable price to other ...

The costs of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump ...